0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 21-40 of 895 Articles
JAMA Internal Medicine | 
Original Investigation | 
Loes Jaspers, MD; Frederik Feys, MSc, PhD; Wichor M. Bramer, BSc; et al.
JAMA Intern Med. 2016;176(4):453-462. doi:10.1001/jamainternmed.2015.8565.
Includes: CME, Supplemental Content

JAMA Dermatology | 
Observation | 
Olivia Leigh Quach, MD; Sylvia Hsu, MD
JAMA Dermatol. 2016;152(4):486-487. doi:10.1001/jamadermatol.2015.4992.

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Filippo Montemurro, MD; Gloria Mittica, MD; Celeste Cagnazzo, PhD; et al.
JAMA Oncol. 2016;2(4):445-452. doi:10.1001/jamaoncol.2015.4720.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Maxine Sun, MPH; Toni K. Choueiri, MD; Ole-Petter R. Hamnvik, MD; et al.
JAMA Oncol. 2016;2(4):500-507. doi:10.1001/jamaoncol.2015.4917.

JAMA Oncology | 
Original Investigation | 
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. 2016;2(4):529-534. doi:10.1001/jamaoncol.2015.5927.
Includes: CME

JAMA Ophthalmology | 
Observation | 
Ah Ran Cho, MD; Young Hee Yoon, MD
JAMA Ophthalmol. 2016;134(4):463-464. doi:10.1001/jamaophthalmol.2015.5966.

JAMA Neurology | 
Editorial | 
Lewis H. Kuller, MD, DrPH
JAMA Neurol. 2016;73(4):379-381. doi:10.1001/jamaneurol.2015.4931.

JAMA Neurology | 
Original Investigation | 
Willy Gomm, PhD; Klaus von Holt, MD, PhD; Friederike Thomé, MSc; et al.
JAMA Neurol. 2016;73(4):410-416. doi:10.1001/jamaneurol.2015.4791.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Rodrigue S. Allodji, PhD; Ibrahima Diallo, PhD; Chiraz El-Fayech, MD; et al.
JAMA Ophthalmol. 2016;134(4):390-397. doi:10.1001/jamaophthalmol.2015.6088.
Includes: CME, Supplemental Content

JAMA Ophthalmology | 
Brief Report | 
Hsin-Yu Liu, MD; Po-Ting Yeh, MD; Kuan-Ting Kuo, MD; et al.
JAMA Ophthalmol. 2016;134(4):449-452. doi:10.1001/jamaophthalmol.2016.0001.

JAMA Cardiology | 
Original Investigation |  FREE
John A. Dodson, MD, MPH; Andrew Petrone, MPH; David R. Gagnon, MD, MPH, PhD; et al.
JAMA Cardiol. 2016;1(1):65-72. doi:10.1001/jamacardio.2015.0345.
Includes: Supplemental Content

JAMA Ophthalmology | 
Invited Commentary | 
Brian L. VanderBeek, MD, MPH, MSCE
JAMA Ophthalmol. 2016;134(4):422-423. doi:10.1001/jamaophthalmol.2016.0240.

JAMA Ophthalmology | 
Original Investigation | 
Fanny Raguideau, PharmD; Magali Lemaitre, PhD; Rosemary Dray-Spira, MD, PhD; et al.
JAMA Ophthalmol. 2016;134(4):415-421. doi:10.1001/jamaophthalmol.2015.6205.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Brittany G. Craiglow, MD; Daniel Tavares, PharmD; Brett A. King, MD, PhD
JAMA Dermatol. 2016;152(4):490-491. doi:10.1001/jamadermatol.2015.4445.

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Jaehwan Kim, MD, PhD; Dong Joo Kim, MD; Francesca S. Ortenzio, MD; et al.
JAMA Dermatol. Published online March 30, 2016. doi:10.1001/jamadermatol.2016.0501

JAMA Dermatology | 
Observation |  ONLINE FIRST
Ashwin Agarwal, BS; Willis Barrow, MD; M. Angelica Selim, MD; et al.
JAMA Dermatol. Published online March 30, 2016. doi:10.1001/jamadermatol.2016.0503

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Brief Report  | 
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib A Phase 2 Clinical Trial
Mark A. Dickson, MD; Gary K. Schwartz, MD; Mary Louise Keohan, MD; et al.
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Cardiovascular Disease After Aromatase Inhibitor Use
Reina Haque, PhD; Jiaxiao Shi, PhD; Joanne E. Schottinger, MD; et al.
JAMA Dermatology
Original Investigation  | 
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma A Systematic Review and Pooled Analysis of Interventional Studies
Audrey A. Jacobsen, BA; Adam S. Aldahan, BS; Olivia B. Hughes, BS; et al.